Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| REGENERON PHARMACEUTICALS, INC. | 214,523 | reported | 31 Dec 2025 | tx 345+9,024,583−8,915,550 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 31 Dec 2025 | TAX_WITHHOLDING | REGENERON PHARMACEUTICALS, INC. | 28,570 | 772.09 USD | |
| 31 Dec 2025 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 28,570 | 0.00 USD | |
| 31 Dec 2025 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 28,570 | 0.00 USD | deriv |
| 09 Dec 2025 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 172,723 | 555.67 USD | |
| 09 Dec 2025 | TAX_WITHHOLDING | REGENERON PHARMACEUTICALS, INC. | 155,145 | 701.51 USD | |
| 09 Dec 2025 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 172,723 | 0.00 USD | deriv |
| 11 Jun 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 7,321 | 1015.28 USD | |
| 12 Jun 2024 | CONVERSION | REGENERON PHARMACEUTICALS, INC. | 1,000 | 0.00 USD | |
| 12 Jun 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 270 | 1016.62 USD | |
| 12 Jun 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 14,879 | 1015.30 USD | |
| 11 Jun 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 1,743 | 1016.04 USD | |
| 12 Jun 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 1,000 | 1025.27 USD | |
| 12 Jun 2024 | CONVERSION | REGENERON PHARMACEUTICALS, INC. | 1,000 | 0.00 USD | deriv |
| 06 Jun 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 787 | 1015.02 USD | |
| 17 May 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 22,687 | 979.22 USD | |
| 17 May 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 143 | 980.07 USD | |
| 13 May 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 203,204 | 399.66 USD | |
| 15 May 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 299 | 988.76 USD | |
| 13 May 2024 | TAX_WITHHOLDING | REGENERON PHARMACEUTICALS, INC. | 144,433 | 976.79 USD | |
| 14 May 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 22,698 | 979.16 USD | |
| 14 May 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 2,302 | 980.10 USD | |
| 15 May 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 7,864 | 979.05 USD | |
| 15 May 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 295 | 980.64 USD | |
| 15 May 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 1,081 | 981.50 USD | |
| 15 May 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 235 | 982.66 USD |